Study suggests COVID-19 vaccination lowers incidence of arterial thromboses
A second dose of the vaccine lowered the incidence of conditions such as heart attack or stroke
Read More
Tag: University of Edinburgh
Study reveals AI insights can predict development of disease a decade in advance
The study predicted the development of conditions including Alzheimer’s and heart disease
Read More
Study finds 3D-printed blood vessels could improve heart bypass outcomes
Coronary heart disease is the most common form of heart and circulatory disease
Read More
Study finds pain gene affects success of chronic pain medicine in women
Chronic pelvic pain is a disabling condition that affects around one in four women worldwide
Read More
Female cancer survivors at low risk of developing obstetric complications
According to WHO, around 15% of pregnant women will develop an obstetric complication
Read More
Resolution unveils data for liver disease treatment at EASL 2024
Extended phase 2 study highlights macrophage cell therapy’s efficacy
Read More
Scientists reveal new method that could reduce waste from drug manufacturing
The new method could help to prevent severe side effects caused by enantiomer drugs
Read More
Study links dementia antipsychotics to higher risks of serious health outcomes
The neurodegenerative condition currently affects more than 944,000 people living in the UK
Read More
Study reveals new aptamer targeting tool can detect early signs of motor neurone disease
The fatal, progressive neurological condition currently affects around 5,000 people in the UK
Read More
Womb condition checks could reduce cancer risk in endometrial hyperplasia
Women with atypical endometrial hyperplasia have an increased risk of developing cancer
Read More
New clinical study to advance development of treatments for liver cirrhosis
The £30m ADVANCE study is the most extensive study into liver disease worldwide
Read More
Parkinson’s UK awards over £1.8m for nine research projects
Around 145,000 people in the UK are living with Parkinson’s disease
Read More
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
- Zenas reports strong phase 3 results for obexelimab in IgG4-related disease
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
